BRIEF-Pfizer And Biontech Receive Conditional Marketing Authorization By Swissmedic For COVID-19 Vaccine

BRIEF-Pfizer And Biontech Receive Conditional Marketing Authorization By Swissmedic For COVID-19 Vaccine

Pfizer Inc:

* PFIZER AND BIONTECH RECEIVE CONDITIONAL MARKETING AUTHORIZATION BY SWISSMEDIC FOR COVID-19 VACCINE

* DELIVERIES WILL START IN 2020 AND WILL OCCUR THROUGHOUT 2021 IN ACCORDANCE WITH TERMS OF THE SUPPLY AGREEMENT Source text: https://bit.ly/3mzgtcA Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.